0000899243-21-044266.txt : 20211112 0000899243-21-044266.hdr.sgml : 20211112 20211112062412 ACCESSION NUMBER: 0000899243-21-044266 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211108 FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Melrose Evan S CENTRAL INDEX KEY: 0001373063 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41018 FILM NUMBER: 211399189 MAIL ADDRESS: STREET 1: 1000 MAIN STREET STREET 2: SUITE 3250 CITY: HOUSTON STATE: TX ZIP: 77002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spindletop Health Acquisition Corp. CENTRAL INDEX KEY: 0001848558 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 862141947 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7000 N. MOPAC, SUITE 315 CITY: AUSTIN STATE: TX ZIP: 79731 BUSINESS PHONE: 5129614633 MAIL ADDRESS: STREET 1: 7000 N. MOPAC, SUITE 315 CITY: AUSTIN STATE: TX ZIP: 79731 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-08 0 0001848558 Spindletop Health Acquisition Corp. SCHAU 0001373063 Melrose Evan S C/O SPINDLETOP HEALTH ACQUISITION CORP. 3571 FAR WEST BLVD., SUITE 108 AUSTIN TX 78731 1 1 0 0 CEO and CFO Private Warrants 11.50 2021-11-08 4 P 0 12600000 1.00 A Class A Common Stock 12600000 12600000 I By Spindletop Health Sponsor Group, LLC The Private Warrants will become exercisable on the later of 30 days after the completion of the Company's initial business combination or 12 months from the completion of the Company's initial public offering. The Private Warrants will expire on the fifth anniversary of the Company's completion of its initial business combination. The Private Warrants are held directly by Spindletop Health Sponsor Group, LLC (the "Sponsor"). The Private Warrants held by the Sponsor are beneficially owned by Dr. Evan Melrose, Spindletop Health Acquisition Corp.'s Chief Executive Officer and Chief Financial Officer. Dr. Melrose is also the Manager of the Sponsor, who has sole voting and dispositive power over all securities held by the Sponsor. /s/ Evan Melrose 2021-11-11